Figure 1 | Scientific Reports

Figure 1

From: Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage

Figure 1The alternative text for this image may have been generated using AI.

Tumor ascitic fluid volume and count of live and/or dead EAC cells in EAC-bearing mice after treatment with amygdalin and/or sorafenib. Data were presented as means ± SEM (n = 7). Small (a–e) letters showed the marked change at P ≤ 0.05. The significant were expressed by dissimilar letters above columns with the same color.

Back to article page